Letter to the Editor regarding the paper by Park et al., Extra-gain of HER2-positive cases through HER2 reassessment in primary and metastatic sites in advanced gastric cancer with initially HER2-negative primary tumours: Results of GASTric cancer HER2 reassessment study 1 (GASTHER1)

Ieni A.; Angelico G.; Zeppa P.; Tuccari G.

首页> 外文期刊>European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) >Letter to the Editor regarding the paper by Park et al., Extra-gain of HER2-positive cases through HER2 reassessment in primary and metastatic sites in advanced gastric cancer with initially HER2-negative primary tumours: Results of GASTric cancer HER2 reassessment study 1 (GASTHER1)

【24h】

Letter to the Editor regarding the paper by Park et al., Extra-gain of HER2-positive cases through HER2 reassessment in primary and metastatic sites in advanced gastric cancer with initially HER2-negative primary tumours: Results of GASTric cancer HER2 reassessment study 1 (GASTHER1)

机译：通过Park等人的案例，通过HER2在晚期胃癌中的重新评估，预先胃2阴性原发性肿瘤，通过HER2阳性病例的额外增益来发信，胃癌患者：胃癌EM2重新评估研究的结果1（ gasther1）

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)》 |2017年第2017期|共2页
作者
Ieni A.; Angelico G.; Zeppa P.; Tuccari G.;
展开▼
作者单位

Univ Messina Dept Human Pathol Adult &

Dev Age Gaetano Barresi Anat Pathol Unit AOU Policlin G;

Univ Catania Dept Med &

Surg Sci &

Adv Technol GF Ingrassia Policlin Vittorio Emanuele Anat;

Hosp San Giovanni di Dio &

Ruggi dAragona Salerno Dept Pathol Salerno Italy;

Univ Messina Dept Human Pathol Adult &

Dev Age Gaetano Barresi Anat Pathol Unit AOU Policlin G;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
专利

1. Letter to the Editor regarding the paper by Park et al., Extra-gain of HER2-positive cases through HER2 reassessment in primary and metastatic sites in advanced gastric cancer with initially HER2-negative primary tumours: Results of GASTric cancer HER2 reassessment study 1 (GASTHER1) [J] . Ieni A., Angelico G., Zeppa P., European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2017,第期

机译：通过Park等人的案例，通过HER2在晚期胃癌中的重新评估，预先胃2阴性原发性肿瘤，通过HER2阳性病例的额外增益来发信，胃癌患者：胃癌EM2重新评估研究的结果1（ gasther1）
2. Loss of HER2 positivity after anti-HER2 chemotherapy in HER2-positive gastric cancer patients: results of the GASTric cancer HER2 reassessment study 3 (GASTHER3) [J] . Seo Seyoung, Ryu Min-Hee, Park Young Soo, Gastric cancer: official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association . 2019,第3期

机译：HER2阳性胃癌患者抗HER2化疗后HER2积极性的丧失：胃癌HER2重新评估研究的结果3（GASTHER3）
3. HER2-positive patients receiving trastuzumab treatment have a comparable prognosis with HER2-negative advanced gastric cancer patients: A prospective cohort observation [J] . QiuM.-Z., LiQ., WangZ.-Q., International Journal of Cancer =: Journal International du Cancer . 2014,第10期

机译：接受曲妥珠单抗治疗的HER2阳性患者的预后与HER2阴性的晚期胃癌患者的预后相当：前瞻性队列观察
4. A nCounter CNV Assay to Detect HER2 Amplification: A Correlation Study with Immunohistochemistry and Fluorescence In Situ Hybridization in a Cohort of 220 Advanced Gastric Cancer Tissues [C] . Kyoung-Mee Kim, Soomin Ahn, Mineui Hong, International Molecular Medicine Tri-Conference. . 2016

机译：NCounter CNV测定检测HER2扩增：在220个晚期胃癌组织队列中的免疫组织化学和荧光的相关性研究
5. A phase Ib study of safety and pharmacokinetics of trastuzumab emtansine and pertuzumab in Japanese patients with HER2-positive metastatic breast cancer [D] . NOGUCHI, Emi 2019

机译：Ib期研究曲妥珠单抗氨丹宁和帕妥珠单抗在日本HER2阳性转移性乳腺癌患者中的安全性和药代动力学
6. Difference of molecular alterations in HER2-positive and HER2-negative gastric cancers by whole-genome sequencing analysis [O] . Chenfei Zhou, Xiaojing Feng, Fei Yuan, 2018

机译：全基因组测序分析HER2阳性和HER2阴性胃癌分子改变的差异
7. Loss of HER2 positivity after anti-HER2 chemotherapy in HER2-positive gastric cancer patients: results of the GASTric cancer HER2 reassessment study 3 (GASTHER3) [O] . Seyoung Seo, Min-Hee Ryu, Young Soo Park, 2018

机译：HER2阳性胃癌患者抗HER2化疗后HER2积极性的丧失：胃癌HER2重新评估研究的结果3（GASTHER3）

Letter to the Editor regarding the paper by Park et al., Extra-gain of HER2-positive cases through HER2 reassessment in primary and metastatic sites in advanced gastric cancer with initially HER2-negative primary tumours: Results of GASTric cancer HER2 reassessment study 1 (GASTHER1)

著录项

相似文献

相关主题

期刊订阅